Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.

Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.

<h4>Objective</h4>In vivo functional changes in white matter during the progression of Alzheimer's disease (AD) have not been previously reported. Our objectives are to measure changes in white matter functional connectivity (FC) in an elderly population undergoing cognitive decline...

Full description

Bibliographic Details
Main Authors:	Yurui Gao, Anirban Sengupta, Muwei Li, Zhongliang Zu, Baxter P Rogers, Adam W Anderson, Zhaohua Ding, John C Gore, Alzheimer’s Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0240513

Similar Items

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
by: Ze Wang, et al.
Published: (2020-11-01)

Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
by: Jinyan Weng, et al.
Published: (2021-01-01)

Rates of decline in Alzheimer disease decrease with age.
by: Dominic Holland, et al.
Published: (2012-01-01)

Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy.
by: Edit Frankó, et al.
Published: (2013-01-01)

White matter and its relationship with cognition in subjective cognitive decline
by: Lisa Ohlhauser, et al.
Published: (2019-12-01)

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
by: Yeonwoo Chung, et al.
Published: (2021-07-01)

Detection of gray matter microstructural changes in Alzheimer’s disease continuum using fiber orientation
by: Peter Lee, et al.
Published: (2020-10-01)

Functional engagement of white matter in resting-state brain networks
by: Muwei Li, et al.
Published: (2020-10-01)

Gender Differences in Elderly With Subjective Cognitive Decline
by: Lijun Wang, et al.
Published: (2018-06-01)

Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
by: Daniel A. Llano, et al.
Published: (2020-11-01)

Topological Measurements of DWI Tractography for Alzheimer’s Disease Detection
by: Nicola Amoroso, et al.
Published: (2017-01-01)

Revealing heterogeneity of brain imaging phenotypes in Alzheimer's disease based on unsupervised clustering of blood marker profiles.
by: Gerard Martí-Juan, et al.
Published: (2019-01-01)

Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.
by: Alexander Schmidt-Richberg, et al.
Published: (2016-01-01)

Data analysis with Shapley values for automatic subject selection in Alzheimer’s disease data sets using interpretable machine learning
by: Louise Bloch, et al.
Published: (2021-09-01)

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study
by: Roy W. E. Van Hooren, et al.
Published: (2018-08-01)

Classification of Alzheimer’s and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
by: Seyed Hossein Nozadi, et al.
Published: (2018-01-01)

How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database
by: Stavros I Dimitriadis, et al.
Published: (2018-01-01)

Specific White Matter Tracts and Diffusion Properties Predict Conversion From Mild Cognitive Impairment to Alzheimer’s Disease
by: David B. Stone, et al.
Published: (2021-07-01)

Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.
by: Juan Felipe Beltrán, et al.
Published: (2020-01-01)

Using path signatures to predict a diagnosis of Alzheimer's disease.
by: P J Moore, et al.
Published: (2019-01-01)

Independent component analysis-based identification of covariance patterns of microstructural white matter damage in Alzheimer's disease.
by: Xin Ouyang, et al.
Published: (2015-01-01)

Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer's disease
by: Alzheimer's Disease Neuroimaging Initiative, et al.
Published: (2022)

ALTEA: A Software Tool for the Evaluation of New Biomarkers for Alzheimer’s Disease by Means of Textures Analysis on Magnetic Resonance Images
by: Carlos López-Gómez, et al.
Published: (2018-07-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone
by: Erin E. Sundermann, et al.
Published: (2020-06-01)

The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline
by: Haifeng Chen, et al.
Published: (2020-05-01)

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features
by: Asha Singanamalli, et al.
Published: (2017-08-01)

Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study
by: Liu, C., et al.
Published: (2021)

Random forest prediction of Alzheimer's disease using pairwise selection from time series data.
by: P J Moore, et al.
Published: (2019-01-01)

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
by: Christoforos Hadjichrysanthou, et al.
Published: (2020-06-01)

Prediction and classification of Alzheimer disease based on quantification of MRI deformation.
by: Xiaojing Long, et al.
Published: (2017-01-01)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
by: Luise Christine Löwe, et al.
Published: (2016-01-01)

Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
by: Hyuk Jin Yun, et al.
Published: (2015-01-01)

Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer’s Disease
by: Florian U. Fischer, et al.
Published: (2021-02-01)

Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease.
by: Perry G Ridge, et al.
Published: (2013-01-01)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
by: Nicholas C. Cullen, et al.
Published: (2020-09-01)

Identification of Alzheimer’s Disease on the Basis of a Voxel-Wise Approach
by: Iman Beheshti, et al.
Published: (2019-07-01)

Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images
by: Manhua Liu, et al.
Published: (2018-06-01)

Network propagation of rare variants in Alzheimer's disease reveals tissue-specific hub genes and communities.
by: Marzia Antonella Scelsi, et al.
Published: (2021-01-01)

Osteoarthritis Was Associated With a Faster Decline in Hippocampal Volumes in Cognitively Normal Older People
by: Xiang Li, et al.
Published: (2020-08-01)